Xtant Medical Holdings, Inc. XTNT

0.38 0.00 0.00% as of 25 Sep
Market cap
$52.9M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.12
P/S ratio
0.08 0.12 0.26 0.33 0.64 0.87 1.09 1.58 0.50 0.81
P/FCF ratio
0.00 0.00 22.37 0.00 0.00 0.00 0.00 0.00 0.00 10.47
P/Operating CF
(2.21) 15.97 9.49 (296.65) 37.34 113.13 (27.55) (157.49) 88.44 20.23
P/B ratio
0.00 0.00 0.00 0.00 2.36 1.55 1.84 2.81 1.37 2.14
Price to Tangible BV
0.00 0.00 0.00 0.00 3.15 1.75 2.06 4.24 2.15 2.44
EV/Sales
1.50 2.56 2.16 1.43 0.94 0.81 1.00 1.75 0.74 0.87
EV/EBITDA
0.00 0.00 0.00 104.09 37.62 0.00 0.00 0.00 0.00 9.35
EV/Operating CF
(9.37) (389.79) 128.60 (224.31) (68.34) 102.46 (10.88) (16.82) (7.30) 9.32
EV/FCF
(6.68) (98.40) 184.45 (96.80) (24.55) (31.00) (8.42) (14.83) (5.55) 11.24
Quick Ratio
0.69 0.60 1.39 1.64 0.36 2.31 2.06 1.16 0.94 1.19
Current Ratio
1.57 1.54 2.88 3.43 1.22 4.00 3.24 2.82 2.35 2.65
Net Debt/EBITDA
(421.63) (4.63) (1.34) 80.42 11.87 1.14 0.90 (2.29) (3.56) 0.65
Debt/Assets
90.56% 131.45% 169.25% 178.00% 43.65% 28.36% 25.87% 23.65% 36.45% 26.97%
Debt/Equity
(18.45) (2.37) (1.79) (1.74) 1.25 0.50 0.46 0.43 0.80 0.50
Asset Turnover
0.63 0.66 0.95 1.44 1.26 1.15 1.01 1.19 1.26 1.42
Operating CF/Net income
0.74 0.01 (0.02) 0.05 0.10 (0.09) 0.63 (14.42) 0.72 2.52
Capex/Depreciation
(0.80) (0.19) (0.06) (0.17) (0.63) (1.42) (1.21) (0.40) (0.88) (0.41)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(2,162.11%) 159.37% 136.82% 18.69% 47.31% (21.36%) (26.09%) 1.54% (34.88%) 10.59%
ROA
(13.67%) (41.96%) (92.16%) (18.36%) (16.60%) (10.09%) (14.77%) 0.86% (17.64%) 5.29%
ROIC
(3.90%) (30.55%) (134.10%) (5.14%) (1.55%) (8.60%) (14.44%) (9.43%) (10.64%) 7.71%
Return on Tangible Assets
(57.83%) (220.27%) (235.23%) (29.84%) (69.79%) (12.61%) (21.27%) 1.31% (33.80%) 9.05%
Average Days of Receivables
77.02 56.17 50.50 57.13 47.08 47.25 68.34 82.88 64.31 48.52
Research and Development Expense of Revenue
3.79% 2.95% 2.36% 1.44% 1.23% 1.57% 1.58% 1.46% 2.03% 1.57%
Selling, General and Administrative Expense of Revenue
66.76% 67.60% 63.35% 67.77% 64.66% 64.19% 65.51% 70.41% 66.43% 55.92%
Intangible Assets out of Total Assets
0.54 0.52 0.08 0.09 0.09 0.07 0.06 0.19 0.17 0.07
Share Based Compensation of Revenue
0.00% 0.00% 0.96% 0.80% 2.03% 4.00% 4.25% 3.00% 3.51% 2.16%
Graham Net Nets
(14.40) (12.09) (2.94) (2.62) 0.13 0.43 0.37 0.16 0.28 0.32
Graham Number
37.56 173.67 21.73 6.84 0.00 0.00 0.00 0.00 0.00 0.58
Earnings Yield
(139.32%) (503.48%) (349.69%) (38.75%) (40.83%) (10.79%) (14.93%) 0.00% (27.27%) 5.23%
Free Cash Flow Yield
(284.99%) (20.85%) 4.47% (4.54%) (5.95%) (3.03%) (10.95%) (7.49%) (26.57%) 9.55%
Revenue per Share
85.23 54.78 6.15 4.91 1.87 0.65 0.62 0.77 0.88 0.96
Operating CF per Share
(13.64) (0.36) 0.10 (0.03) (0.03) 0.01 (0.06) (0.08) (0.09) 0.09
Capex per Share
(5.51) (1.07) (0.03) (0.04) (0.05) (0.02) (0.02) (0.01) (0.03) (0.02)
Free Cash Flow per Share
(19.15) (1.43) 0.07 (0.07) (0.07) (0.02) (0.07) (0.09) (0.12) 0.07
Cash per Share
2.44 1.89 0.58 0.40 0.08 0.22 0.22 0.05 0.05 0.12
Shareholders Equity per Share
(6.70) (38.93) (3.73) (3.36) 0.51 0.36 0.36 0.43 0.32 0.37
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(6.70) (38.93) (3.73) (3.36) 0.51 0.36 0.36 0.43 0.32 0.37
Free Cash Flow
(20.22) (2.15) 0.85 (0.96) (2.03) (1.45) (6.90) (10.80) (15.63) 10.40
Working Capital
17.86 13.88 22.63 22.86 5.72 33.25 34.10 41.88 38.54 48.76
Capital Expenditures
(5.82) (1.61) (0.37) (0.54) (1.30) (1.89) (1.56) (1.28) (3.73) (2.15)
Net Current Asset Value
(102.19) (124.70) (55.52) (55.11) 4.41 20.52 23.26 23.61 16.24 35.05
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.05
Capex to Sales
0.06 0.02 0.01 0.01 0.02 0.03 0.03 0.01 0.03 0.02
Net Profit Margin
(21.66%) (63.44%) (97.09%) (12.71%) (13.17%) (8.77%) (14.64%) 0.72% (14.03%) 3.71%
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.94
Other line items
Depreciation/Fixed assets
0.46 0.85 0.92 0.67 0.48 0.26 0.22 0.37 0.42 0.84
Cash ROIC
(24.01%) (12.58%) (14.33%) (13.50%) (14.53%) (7.37%) (15.84%) (23.00%) (26.41%) 6.77%
Accounts Receivable Turnover
5.24 5.21 6.36 6.43 6.27 7.88 6.44 5.78 5.67 6.96
Accounts Payable Turnover
2.53 3.16 3.60 5.12 7.38 8.19 8.46 6.80 6.55 8.44
Inventory Turnover
1.13 1.34 1.45 1.33 1.01 1.16 1.47 1.32 1.30 1.44
Average Days of Payables
146.37 106.39 82.17 36.03 56.78 41.91 49.31 71.85 58.92 28.26
Days of Inventory on Hand
345.99 251.74 219.90 265.13 412.45 287.62 244.23 375.68 287.48 222.46
Average Receivables
17.19 15.85 11.35 10.06 8.50 7.02 9.00 15.79 20.70 19.23
Average Payables
10.95 10.29 7.97 4.33 2.57 2.78 3.05 5.27 7.49 5.88
Average Inventory
24.48 24.34 19.86 16.70 18.75 19.68 17.62 27.09 37.76 34.45
Average Assets
142.56 124.90 76.06 44.79 42.31 48.08 57.46 76.42 93.22 93.99
Average Common Equity
0.90 (32.89) (51.24) (43.99) (14.85) 22.70 32.53 42.76 47.16 46.96

Fold the line items

Columns are period end dates